Ep. 140 - Turbulence at BIO, Plus 4Q Preview & the Distillery

BioCentury This Week

English - October 11, 2022 01:00 - 29 minutes - 20.2 MB - ★★★★★ - 11 ratings
Science biotech biopharma pharmaceutical research investment dealmaking Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep. 139 - Wins in Neurodegeneration, U.S.-China & Life Science Cares

Next Episode: Ep. 141 - Neoantigen Vaccines, Drug Pricing, U.S.-China & U.K. Turmoil

On the latest BioCentury This Week podcast, Washington Editor Steve Usdin details the circumstances leading up to Michelle McMurry-Heath’s resignation as CEO of BIO on Monday. The podcast team also discuss BioCentury’s 4Q22 Financial Markets Preview, with Associate Editor Stephen Hansen assessing biotech’s attempt to emerge from the ongoing bear market recovery as inflation and rising interest rates foster a risk-off environment. Senior Editor Karen Tkach Tuzman discusses the latest translational tidbits from BioCentury’s Distillery and the impact Nobel Prize laureate Carolyn Bertozzi has had on the biotech industry.